2 "Defensive" Dividends Growing Fast (Thanks to AI)

Author urges buying dividend-growth names after recent pullbacks: Waste Management (WM) is down ~6% since Middle East hostilities, yields 1.5% but just raised its dividend 14.5% (23rd straight year) and management expects ~30% FCF growth this year; WM is investing $1.4B in automation (2022–2026) and trades at a P/E of 34. Gilead (GILD) is down ~7%, yields ~2.7%, raised its dividend by $0.03 (vs $0.02 prior), saw FCF rise 10% to $3.1B, paid ~$1B in dividends and $230M in buybacks, trades at ~15.7x forward, and has a 25/13/15 Phase 1/2/3 pipeline; the piece positions AI as a secular catalyst to lower development costs, cap wages/inflation, and support dividends.

Analysis

AI adoption in back-office, repetitive physical tasks will be a structural margin lever for non-tech service businesses over the next 12–36 months: for asset-heavy operators this manifests as higher throughput per site, lower variable labor cost per ton/route, and the ability to stretch existing network capacity before adding new capital. That creates a convex free cash flow profile where incremental revenue drops disproportionately to margin degradation risk, turning what looks like a low-yield utility into a growing cash generator when automation adoption accelerates.

In biotech, generative and simulation-driven discovery compresses calendar risk — not just cost-per-candidate — which increases the present value of near-term pipeline assets and raises optionality on late-stage readouts. The second-order dynamic is an M&A arbitrage: buyers will pay higher multiples for small-cap de-risks, and large incumbents with in-house AI stacks benefit both from faster internal cycles and from being acquirers of newly de-risked IP.

Near-term headline risk (geopolitics, rate stickiness) will continue to cause episodic mark-to-market declines; the true bifurcation is multi-quarter: if companies report measurable productivity gains (automation throughput, AI-driven trial cycle reduction) within 2–4 quarters the rerating can be sharp, but absent demonstrable metrics regulators or labor frictions could push realizations beyond 12 months. Watch leading indicator datapoints: site-level robot uptime/throughput, per-route cost trends, trial acceleration metrics and early-stage toxicology failure rates.

Consensus is underweighting the compounder effect of sustained dividend growth powered by structural FCF gains — the market prices these names like cyclical cash cows rather than optionality-rich automation winners. That mismatch creates a 12–24 month asymmetric opportunity, but it is conditional: if rates remain meaningfully higher for longer, multiples could compress enough to offset operational gains, so size and protection matter.

Key Decisions for Investors

• Long WM (core equity) — initiate a starter position (1.5–2.5% NAV) and scale to target (4–6% NAV) on further 5–10% pullbacks; horizon 12–24 months. Hedge entry execution risk by selling short-duration (3–6 month) OTM puts to lower basis only if comfortable owning more on a down-tick. Risk/Reward: expect asymmetric upside if automation metrics accelerate (30–40%+ upside scenario) vs a 15–25% downside if macro multiple compression persists.
• Pair trade: long WM / short RSG (Republic Services) — size as a relative-value pair (net neutral dollar exposure) to express a view that earlier adopters of automation will capture the bulk of margin expansion. Timeframe 6–18 months. Reward if WM outpaces RSG on throughput metrics; risk if RSG announces catch-up tech or industry-wide price increases.
• Directional options on GILD — buy a 9–15 month call spread to cap premium outlay ahead of pipeline readouts and AI-center milestones, or alternatively buy the stock and sell 1–2 quarter covered calls to synthetically boost yield while retaining upside. Timeframe tied to upcoming phase-readouts (3–12 months). Risk/Reward: call spread limits downside to premium paid with 2–4x upside potential if trial cadence and AI productivity prove outsized.
• Portfolio defense / sizing rule — limit combined exposure to dividend-automation themes to 10–12% NAV and size individual positions so that a 20% adverse move in rates or a 30% headline-driven drawdown reduces position to a pre-defined stop-sell level (e.g., trim to half at -15%). Use this to capture mean-reversion while protecting against regime shifts in rates or regulatory setbacks.